These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2967034)

  • 21. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone.
    Atala A; Amin M; Harty JI
    Urology; 1992 Feb; 39(2):108-10. PubMed ID: 1736500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)].
    Quereux C; Ezes H; Deltour G; Decaux J; Dorangeon P; Wahl P
    Sem Hop; 1980 Oct; 56(37-38):1453-9. PubMed ID: 6254160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Agreal: its acceptibility. Review of the literature].
    Brient-Clabaux J
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):167-70. PubMed ID: 3922036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
    Schiff I; Tulchinsky D; Cramer D; Ryan KJ
    JAMA; 1980 Sep; 244(13):1443-5. PubMed ID: 6775094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.
    Fioretti P; Cagnacci A; Paoletti AM; Gambacciani M; Soldani R; Mauro GA; Spinetti A; Melis GB
    J Endocrinol Invest; 1989 May; 12(5):295-301. PubMed ID: 2549113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Climacteric syndrome: comparison of several secondary therapies].
    Bianco V; Colombo A; Tassan Simonat P
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):54-60. PubMed ID: 1929099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of prolactin in the menopause.
    Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
    Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intractable menopausal disorders cured by veralipride (author's transl)].
    Angeli S; Fougère P
    Sem Hop; 1982 Jan; 58(2):111-2. PubMed ID: 6276994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and tolerance of veralipride in the treatment of flushing in the menopause. A multicenter study].
    Boukobza G
    Rev Fr Gynecol Obstet; 1986 Sep; 81(8):413-7. PubMed ID: 3532280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation into the climacteric in Nigerians.
    Aina AO
    J Med Assoc Thai; 1992 Mar; 75(3):168-72. PubMed ID: 1506795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Actual status of veralipride use.
    Carranza-Lira S
    Clin Interv Aging; 2010 Sep; 5():271-6. PubMed ID: 20852674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and clinical and biological tolerability of the long-term administration of veralipride. Apropos of 74 cases].
    Dargent D; Dumont M; Malinas Y
    Sem Hop; 1983 Nov; 59(40):2778-80. PubMed ID: 6316535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaginal smear cytology and hormonal tests before and after treatment with veralipride. Results in eleven cases (author's transl)].
    Sadrin R; Evrard G; Adnet JJ; Wahl P; Quereux C
    Sem Hop; 1980 Oct; 56(37-38):1460-4. PubMed ID: 6254161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
    Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Moggi L; Fioretti P
    J Clin Endocrinol Metab; 1988 May; 66(5):964-7. PubMed ID: 2834413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
    Masmoudi K; Gras-Champel V; Lemaire-Hurtel AS; Masson H; Munier A; Geslin JM; Andréjak M
    Rev Med Interne; 2005 Jun; 26(6):453-7. PubMed ID: 15936474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.